Ever since e-cigarettes first came on the market in 2006 the argument has been that it will take time for their health benefits to be manifest. This view was restated again last month in an FDA press release that stated, “Companies who want to continue to market their flavored ENDS products must have robust andContinue reading “E-cigs have been on the market for 15 years: If they were really reducing harm it would be obvious by now”
Author Archives: Stanton Glantz
British American Tobacco (BAT) Conducted Extensive and Potentially Illegal Activity To Undermine Health Policy, Sabotage Competitors And Secure Profits In Africa
Researchers led by Anna Gilmore at the University of Bath just published three jaw-dropping reports on British American Tobacco’s (BAT) allegedly illegal activities in Africa to undermine competitors through surveillance, bribes and dirty tricks. (They also contributed 273 new documents to the UCSF Truth Tobacco Industry Documents Library they used in this work, so theContinue reading “British American Tobacco (BAT) Conducted Extensive and Potentially Illegal Activity To Undermine Health Policy, Sabotage Competitors And Secure Profits In Africa”
PMPSA’s Population Health Impact Model for IQOS underestimates the health impact of IQOS, does not adequately address new published research and information on population health impacts, and does not demonstrate benefits to individual or population health, so FDA should not issue an exposure modification MRTP order for IQOS 3
My colleagues and I at the UCSF TCORS submitted this public comment to the FDA. The Regulations.gov tracking number is kta-koyn-mf7k. A PDF is available here. PMPSA’s Population Health Impact Model for IQOS underestimates the health impact of IQOS, does not adequately address new published research and information on population health impacts, and does notContinue reading “PMPSA’s Population Health Impact Model for IQOS underestimates the health impact of IQOS, does not adequately address new published research and information on population health impacts, and does not demonstrate benefits to individual or population health, so FDA should not issue an exposure modification MRTP order for IQOS 3”
PMPSA’s supplemental modified risk tobacco product application for IQOS 3 does not support the conclusion that IQOS will not harm vascular endothelial function and does not address new published research, so FDA should not issue an exposure modification MRTP order for IQOS 3 support the conclusion that IQOS will not harm vascular endothelial function and does not address new published research, so FDA should not issue an exposure modification MRTP order for IQOS 3
My colleagues and I at the UCSF TCORS just submitted this public comment to the FDA. The tracking number on Regulations.gov is kta-aq6w-3tph. A PDF is available here. PMPSA’s supplemental modified risk tobacco product application for IQOS 3 does not support the conclusion that IQOS will not harm vascular endothelial function and does not addressContinue reading “PMPSA’s supplemental modified risk tobacco product application for IQOS 3 does not support the conclusion that IQOS will not harm vascular endothelial function and does not address new published research, so FDA should not issue an exposure modification MRTP order for IQOS 3 support the conclusion that IQOS will not harm vascular endothelial function and does not address new published research, so FDA should not issue an exposure modification MRTP order for IQOS 3”
FDA can and should prioritize youth over Juul and other e-cigs sales while it ponders the long term
After years of delays and deadline extensions that allowed thousands of e-cigarettes to remain on the market without any FDA premarket review and millions of kids to become nicotine addicts, health groups successfully sued FDA to force action. As a result, on July 11, 2019 Judge Paul Grimm ordered FDA to require premarket tobacco product applications (PMTAs) forContinue reading “FDA can and should prioritize youth over Juul and other e-cigs sales while it ponders the long term”
Understanding how unhealthy food companies influence advertising restrictions
Advertising is a key vector used to promote unhealthy products, and there is a long history of efforts to ban or restrict advertising as a key element of tobacco control. Advertising restrictions are also starting to be implemented to protect the public from promotions for other unhealthy products, including junk food. In particular, in 2019Continue reading “Understanding how unhealthy food companies influence advertising restrictions”
IQOS emissions create risks of immunosuppression and pulmonary toxicity and the supplemental modified risk tobacco product application for IQOS 3 does not address new published research on these risks, so FDA should not issue an exposure modification MRTP order for IQOS 3
My colleagues and I at the UCSF TCORS submitted this public comment to the FDA. The Regulations.gov tracking number is kt4-u9mw-wc65. A PDF version is available here. IQOS emissions create risks of immunosuppression and pulmonary toxicity and the supplemental modified risk tobacco product application for IQOS 3 does not address new published research on theseContinue reading “IQOS emissions create risks of immunosuppression and pulmonary toxicity and the supplemental modified risk tobacco product application for IQOS 3 does not address new published research on these risks, so FDA should not issue an exposure modification MRTP order for IQOS 3”
President Biden willing to eliminate vaping
At a campaign stop on January 6, 2020, then-candidate Joe Biden said he would prioritize health over business and eliminate vaping if the evidence showed damage to lungs and other bad effects. E-cigs do damage lungs and much more. So the FDA doesn’t have to worry about the President blocking them as Obama and TrumpContinue reading “President Biden willing to eliminate vaping”
e-cigs are a gateway to cannabis too: evidence from Germany
In addition to the sizable literature showing that e-cigarettes are attracting many kids at low risk of initiating nicotine use with cigarettes to nicotine, many of whom go on to smoke cigarettes, there is strong consistent evidence that e-cigarettes are a gateway to the cannabis use in the USA. Now Ann-Kathrin Seidel and her colleaguesContinue reading “e-cigs are a gateway to cannabis too: evidence from Germany”
Tobacco documents: The end of the beginning
When I got the first box of around 4000 pages of secret tobacco industry documents on May 12, 1994, I thought they would have an impact, but didn’t have a clue as to how big that impact would be. Being able to look inside the tobacco companies to appreciate — in their own words —Continue reading “Tobacco documents: The end of the beginning”
Stanton Glantz blog 